900m lives depend on livestock

GALVmed makes livestock vaccines, medicines and diagnostics accessible and affordable to the millions in developing countries for whom livestock is a lifeline

About GALVmed

Neurocysticercosis, a human disease transmitted from pigs with porcine cysticercosis (PC), causes 30% of human epilepsy cases in the developing world.

The disease is estimated to cause around 5 million human cases and 50,000 human deaths each year.

This is a disease that affects the poor and those who have neurocysticercosis are often stigmatised in their communities.

The first-ever licensed PC vaccine became available in India at the end of 2016 at US $1 for 2 doses to vaccinate a pig.

Tackling the major cause of epilepsy in the developing world

Our work

Product development

GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.

Market development

Our work with our partners supports the poor livestock keepers of the world.

Policy and advocacy

The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.

Blog

Experts take stock of the East Coast Fever vaccine performance in Uganda

On June 8, 2017, the Global Alliance for Livestock Veterinary Medicines (GALVmed) convened a workshop in Kampala, Uganda, aimed at presenting the findings on the safety and protection of East Coast Fever-Infection Treatment Method (ECF-ITM) …

Developing the market for unserved smallholder poultry keepers in India

Collectively, smallholder poultry farmers around the world provide a large market for livestock veterinary products. But this crucial segment has traditionally been unserved by pharmaceutical companies, often because smallholder markets are viewed as non-profitable and …

New tools to tackle porcine cysticercosis in rural Uganda

Porcine Cysticercosis is a serious zoonotic disease prevalent in many parts of the world especially in developing countries, where sanitation remains a challenge. It causes 30% of human epilepsy cases in the developing world.

A GALVmed-led …